Physalin D

Physalin D
Product Name Physalin D
CAS No.: 54980-22-2
Catalog No.: CFN92939
Molecular Formula: C28H32O11
Molecular Weight: 544.55 g/mol
Purity: >=98%
Type of Compound: Steroids
Physical Desc.: Powder
Targets: TNF-α | Antifection
Source: The herbs of Physalis alkekengi
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $388/5mg
Physalin D shows antimalarial activity; it also exhibits a minimum inhibitory concentration value (MIC) against Mycobacterium tuberculosis H(37)Rv strain of 32 microg/mL. Physalin D displays considerable cytotoxicity against several cancer cell lines. It presents antinociceptive properties associated with central.
Inquire / Order:
Technical Inquiries:
Tel: +86-27-84237783
Fax: +86-27-84254680

1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to:

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Front Pharmacol.2021, 12:652860.
  • Korean Journal of Plant Resources2021, 34(1):52-58.
  • Cell Death Differ.2021, 1-8.
  • Horticulturae2020, 6(4),76.
  • Evid Based Complement Alternat Med.2021, 2021:5023536.
  • Pharmacogn J.2022, 14(2):350-357
  • Phytomedicine.2022, 100:154058.
  • Exp Parasitol.2015, 153:160-4
  • Pharmacognosy Journal.2020, 12(2), p232-235.
  • Phytochemistry2018, 15:83-92
  • Physalin X

    Catalog No: CFN95329
    CAS No: 72497-31-5
    Price: $318/5mg
    Taccalonolide A

    Catalog No: CFN90596
    CAS No: 108885-68-3
    Price: $288/10mg
    Taccalonolide AJ

    Catalog No: CFN90935
    CAS No: 1349904-82-0
    Price: $318/5mg
    Physalin L

    Catalog No: CFN90166
    CAS No: 113146-74-0
    Price: $288/5mg
    Physalin A

    Catalog No: CFN92940
    CAS No: 23027-91-0
    Price: $318/5 mg
    Physalin O

    Catalog No: CFN95097
    CAS No: 120849-18-5
    Price: $413/5mg
    Isophysalin A

    Catalog No: CFN92936
    CAS No: 1363398-67-7
    Price: $318/5mg
    Physalin C

    Catalog No: CFN92938
    CAS No: 27503-33-9
    Price: Inquiry(
    Physalin B

    Catalog No: CFN92941
    CAS No: 23133-56-4
    Price: Inquiry(
    Physalin D

    Catalog No: CFN92939
    CAS No: 54980-22-2
    Price: $388/5mg
    Parasitology. 2013 Dec;140(14):1811-21.
    Physalins B and F, seco-steroids isolated from Physalis angulata L., strongly inhibit proliferation, ultrastructure and infectivity of Trypanosoma cruzi.[Pubmed: 24001147]
    We previously observed that physalins have immunomodulatory properties, as well as antileishmanial and antiplasmodial activities.
    Here, we investigated the anti-Trypanosoma cruzi activity of physalin B, Physalin D, physalin F and physalin G. We found that physalin B and physalin F were the most potent compounds against trypomastigote and epimastigote forms of T. cruzi. Electron microscopy of trypomastigotes incubated with physalin B showed disruption of kinetoplast, alterations in Golgi apparatus and endoplasmic reticulum, followed by the formation of myelin-like figures, which were stained with MDC to confirm their autophagic vacuole identity. Physalin B-mediated alteration in Golgi apparatus was likely due to T. cruzi protease perturbation; however physalins did not inhibit activity of the trypanosomal protease cruzain. Flow cytometry examination showed that cell death is mainly caused by necrosis. Treatment with physalins reduced the invasion process, as well as intracellular parasite development in macrophage cell culture, with a potency similar to benznidazole. We observed that a combination of physalins and benznidazole has a greater anti-T. cruzi activity than when compounds were used alone.
    These results indicate that physalins, specifically B and F, are potent and selective trypanocidal agents. They cause structural alterations and induce autophagy, which ultimately lead to parasite cell death by a necrotic process.
    Phytother Res. 2002 Aug;16(5):445-8.
    Antimycobacterial physalins from Physalis angulata L. (Solanaceae).[Pubmed: 12203265]
    Crude extracts and fractions from aerial parts of Physalis angulata have been bioassayed for antimycobacterial activity.
    Fraction A1-29-12 containing Physalin B,physalin F and Physalin D exhibited a minimum inhibitory concentration value (MIC) against Mycobacterium tuberculosis H(37)Rv strain of 32 microg/mL. Purified Physalin B and Physalin D were also tested showing MIC values against Mycobacterium tuberculosis H(37)Rv strain of > 128 microg/mL and 32 microg/mL respectively, suggesting that Physalin D plays a relevant role in the antimycobacterial activity displayed.
    Structural elucidation of both Physalin D and Physalin B was based on detailed (13)C and (1)H NMR spectral analysis with the aid of 2D-correlation spectroscopy ((1)H-(1)H, COSY, HSQC and HMBC). The assignment of the (13)C chemical shift for Physalin D is reported here for the first time.
    J Nat Prod. 2011 Oct 28;74(10):2269-72.
    Antimalarial activity of physalins B, D, F, and G.[Pubmed: 21954931]
    The antimalarial activities of Physalin B, Physalin D, physalin F, and physalin G (1-4), isolated from Physalis angulata, were investigated.
    In silico analysis using the similarity ensemble approach (SEA) database predicted the antimalarial activity of each of these compounds, which were shown using an in vitro assay against Plasmodium falciparum. However, treatment of P. berghei-infected mice with 3 increased parasitemia levels and mortality, whereas treatment with 2 was protective, causing a parasitemia reduction and a delay in mortality in P. berghei-infected mice.
    The exacerbation of in vivo infection by treatment with 3 is probably due to its potent immunosuppressive activity, which is not evident for 2.
    J Pharm Pharmacol. 2006 Feb;58(2):235-41.
    In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata.[Pubmed: 16451752 ]
    We have evaluated the in-vitro and in-vivo antitumour activity of physalin B and Physalin D isolated from the aerial parts of Physalis angulata.
    In-vitro, both compounds displayed considerable cytotoxicity against several cancer cell lines, showing IC50 values in the range of 0.58 to 15.18 microg mL(-1) for physalin B, and 0.28 to 2.43 microg mL(-1) for Physalin D. The antitumour activity of both compounds was confirmed in-vivo using mice bearing sarcoma 180 tumour cells. The in-vivo antitumour activity was related to the inhibition of tumour proliferation, as observed by the reduction of Ki67 staining in tumours of treated animals. Histopathological examination of the kidney and liver showed that both organs were affected by physalin treatment, but in a reversible manner.
    These compounds were probably responsible for the previously described antitumour activity of ethanol extracts of P. angulata, and their identification and characterization presented here could explain the ethnopharmacological use of this species in the treatment of cancer.
    J Nat Prod. 2014 Nov 26;77(11):2397-403.
    Antinociceptive properties of physalins from Physalis angulata.[Pubmed: 25396337 ]
    Pain is the most common reason a patient sees a physician. Nevertheless, the use of typical painkillers is not completely effective in controlling all pain syndromes; therefore further attempts have been made to develop improved analgesic drugs. The present study was undertaken to evaluate the antinociceptive properties of physalin B (1), Physalin D (2), physalin F (3), and physalin G (4) isolated from Physalis angulata in inflammatory and centrally mediated pain tests in mice.
    Systemic pretreatment with 1-4 produced dose-related antinociceptive effects on the writhing and formalin tests, traditional screening tools for the assessment of analgesic drugs. On the other hand, only 3 inhibited inflammatory parameters such as hyperalgesia, edema, and local production of TNF-α following induction with complete Freund's adjuvant. Treatment with 1, 3, and 4 produced an antinociceptive effect on the tail flick test, suggesting a centrally mediated antinociception. Reinforcing this idea, 2-4 enhanced the mice latency reaction time during the hot plate test. Mice treated with physalins did not demonstrate motor performance alterations.
    These results suggest that 1-4 present antinociceptive properties associated with central, but not anti-inflammatory, events and indicate a new pharmacological property of physalins.

    Catalog No: CFN95023
    CAS No: 74690-74-7
    Price: $318/5mg

    Catalog No: CFN95161
    CAS No: 201012-14-8
    Price: $318/10mg

    Catalog No: CFN95250
    CAS No: 440094-38-2
    Price: $413/5mg
    New compound 6

    Catalog No: CFN95259
    CAS No: N/A
    Price: $413/5mg

    Catalog No: CFN95349
    CAS No: N/A
    Price: $318/5mg

    Catalog No: CFN95356
    CAS No: 102582-69-4
    Price: $318/5mg
    Dipsacus saponin X

    Catalog No: CFN95359
    CAS No: 146100-01-8
    Price: $318/20mg

    Catalog No: CFN95387
    CAS No: 56973-42-3
    Price: $318/5mg

    Catalog No: CFN95388
    CAS No: 70561-31-8
    Price: $318/10mg

    Catalog No: CFN95409
    CAS No: 120786-76-7
    Price: $413/5mg